| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Kern Regional Center is one of 21 private, nonprofit regional centers contracted by the State of California through the Department of Developmental Services (DDS) to coordinate community-based services and support for individuals with developmental disabilities and their families. KRC serves nearly 8,000 clients in Kern, Inyo and Mono Counties. Our counties cover approximately 22,000 square miles with a population of almost 900,000 people
RIO attains its goal of improving the quality of life of disabled persons by providing comprehensive, coordinated programs which increase the ability of disabled individuals to function at home and at school, on the job, and in the community. RIO was established in 1950 to serve the multi-faceted needs of persons with functional disabilities caused by birth defects, medical condition or accidents. Services are provided without regard to age, race, creed, sexual orientation, and gender.
County Medical Services Program is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
KeyMedical Software is a Lebanon, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.